FBL and ovarian carcinoma: Fbl silencing inhibited the proliferation of ovarian cancer cells with stable overexpression of SNORD89. Therefore, we believe that SNORD89 may promote the development and progression of endometrial cancer by influencing the 2′-O-methylation modification of target genes.